ENSAYOS clínicos

Estudio de BMS-986253 en combinación con nivolumab en cánceres avanzados
Dr. Ignacio Javier Melero Bermejo - Medical Oncology
El objetivo de este estudio es explorar posibles cambios en su tumor y su estado de salud general después de que reciba un fármaco experimental, llamado BMS-986253, junto con otro fármaco experimental, llamado nivolumab
- Estudio fase 1/2a de BMS-986253 en combinación con nivolumab en cánceres avanzados. Inmunoterapia
- Code EudraCT: 2018-000340-26
- Protocol number: CA027-002
- Promoter: Bristol Myers Squibb
- LINK TO CLINICAL TRIALS
* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.
tal vezLE INTERESE
WHAT TECHNOLOGY
DO WE USE?
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

OUR
PROFESSIONALS
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

WHY CHOOSE
THE CLINICA?
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.
